Skip to main content
CRMD logo

CRMD

CorMedix Inc.

$7.39

0.94%

Trade Ideas Performance

Latest Closed Trade Idea

$7.39

0.94%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

10

Social

21

About

Events of CorMedix Inc. (CRMD)

Over the past six months (April-October 2026), CorMedix's stock experienced several events. In May 2026, strong Q1 2026 financial results, driven by DefenCath sales and a favorable change in sales allowances, along with positive Phase III results for REZZAYO, caused the stock to jump. In June 2026, CorMedix Therapeutics won a victory in Minocin® Patent Litigation. The stock saw some downward movement in July 2026. In August 2026, strong Q2 2026 financial results, continued DefenCath sales, and a new multi-year supply agreement with a Large Dialysis Operator led to another stock jump. In September 2026, CorMedix participated in a healthcare conference, and analysts upgraded the stock to 'Buy' with a significant upside prediction. As of October 2, 2026, the share price was $7.19, representing a 37.80% decline from October 6, 2025, with a 52-week range of $6.13 to $13.02.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)